small ruminants
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα

RESPIRATORY PROBLEMS: just another problem or something more serious?

  • October 21, 2020
Facebook
Twitter
LinkedIn
Seeing coughing in a flock of sheep or goats is so common that it is considered normal; many farmers lose some of their animals to pneumonia each year. Generally speaking, respiratory problems are considered to be just another problem on a long list: diarrhoea, toxaemia during gestation, lameness, etc. But is it just another problem? Do we know how it affects the farm’s profitability? Do we underestimate this problem?

 

A SERIOUS PROBLEM… WHICH WE UNDERESTIMATE. WHY?

In the small ruminant sector, there are many conditions that have a negative effect on production, including abortion and diarrhoea, to name but two.

Of all these, respiratory disease is one of the most important, giving rise to significant economic losses and jeopardising animal welfare on farms.

Despite this, respiratory problems still constitute one of the most common problems found in this setting. Somewhat curiously, it is often considered to be “normal” and not a problem, without taking any measure to control it. How is this possible?.

“Respiratory problems are often not considered a major problem”

The answer is simple: in farming, the importance of any problem is proportional to the cost it entails.

Image 1. Ovine Respiratory Complex (ORC) is the leading cause of death in lambs over 23 days old (D. Lacasta et al. 2008). The high mortality rate persists until the end of the fattening period.

The cost of diseases such as this can be difficult to calculate, which, when coupled with the complexity of its control, difficulty in detecting asymptomatic cases and its high incidence on farms, wrongly lead us to underestimate it, considering the problem to be something we can live with, without attempting to solve it.

 

ECONOMIC IMPACT: WHAT MUST WE TAKE INTO ACCOUNT?

When considering the cost, we usually only think of deaths due to pneumonia (direct losses). These are serious, easily detectable clinical cases that result in the death or slaughter of the animal. But this is only the tip of the iceberg.

Image 2. Respiratory diseases follow the tip-of-the-iceberg phenomenon: only clinical cases (animals with symptoms: cough, difficulty breathing, fever, etc.), which represent a very small part of the problem, are noted; and sub-clinical cases (symptom-free but with an affected respiratory tract) go unnoticed.

“Deaths due to pneumonia account for only a small part of the total economic impact.”

Indirect losses must also be considered: these are difficult to calculate and have an even greater economic impact than direct losses.

 

DIRECT Death/slaughter Animals that die or are slaughtered owing to respiratory processes (clinical cases)
Treatment Cost of treatment of symptomatic animals.
INDIRECT Reduction in production Meat: lower Average Daily Gain. Delay in reaching slaughter weight.
Milk: reduced production, shorter lactation, less lactation.
Replacement Increased replacement rate owing to deaths and the shortening of the animal’s productive life.
Other Infertility problems, treatment for relapses, etc.

Table 1. The number of sub-clinical cases causing indirect losses is always much higher than clinical cases (direct losses) on sheep and goat farms. Indirect losses are often not taken into account.

 

INDIRECT LOSSES: THE KEY TO THE PROBLEM!

These losses arise from asymptomatic animals (sub-clinical cases). The proportion of these cases compared to symptomatic cases is enormous. Their diagnosis is complicated and requires a post-mortem examination, which is normally carried out in the abattoir (L.S.B. Mellau et al. 2010).

It is here where we can see the real impact that respiratory disease has on a farm. In abattoir studies, it was observed that 28% of feeder lambs (McRae et al. 2016) and 49% of healthy adult animals (L.M. Ferrer, 2018) slaughtered for consumption had pneumonic lesions.

“28% of feeder lambs and 49% of adult animals had pneumonic lesions”

Image 3. Veterinary inspection in the abattoir. The seizure of lungs due to lesions may exceed 10% in a batch of healthy lambs/kids. These apparently symptom-free animals reach slaughter weight at a later age.

The productive capacity of animals with lung lesions will always be lower than those of healthy animals, resulting in costs that are often unsustainable for the farmer.

Image 4. Many animals with lung lesions of varying severity live with no apparent symptoms. Their production capacity will be affected (indirect losses).

The difficulty in detecting asymptomatic animals, coupled with a very low cure rate (even if they survive, they have lung lesions), makes it even more difficult to understand the severity of the problem.

“In fattening, high treatment failure against Ovine Respiratory Complex: more than 80% survive but less than 20% are lung lesion-free (Gonzalez, J.M. 2015)”

The high percentage of animals with respiratory lesions on farms (with and without symptoms) and their corresponding reduction in production gives us an idea of the immense economic impact that it causes and answers the question about whether this is just another problem…

“Asymptomatic animals with lung lesions will never reach the production levels of healthy animals”

This also opens the door to another question: Should we be doing more to control this problem?

Article written by:

Pablo Núñez Ulibarri. Corporate Product Manager Small Ruminants Unit – HIPRA.

Previous Post

CONTROL OF ENZOOTIC ABORTION: Why has it traditionally been so difficult to control?

Next Post

WHERE DO THE COSTS OWING TO MASTITIS ORIGINATE FROM?

Related Posts

How can we calculate the profitability of vaccination against abortions?

Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

October 21, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

Impact Of Vaccination Against Mastitis In Primiparous Goats: A Study In The Netherlands

Beyond health: the economic impact of resistance

September 14, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

CATEGORIES

  • Antibiotic reduction
  • Field experience
  • Footrot
  • Mastitis
  • Other Goats, Sheep and Lamb Diseases
  • Reproductive
  • Respiratory

NEWSLETTER

DON’T MISS ANY UPDATES ON SMALL RUMINANTS

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Small Ruminants to ask any questions or discuss any concerns you may have about sheep, goats and lambs health prevention.

      I have read and agree to the Privacy Policy and Basic information on Data Protection.

      Next Post
      Analyzing Mastitis costs in sheep and goats (California mastitis test, CMT)

      WHERE DO THE COSTS OWING TO MASTITIS ORIGINATE FROM?

      small ruminants

      Follow us

      Linkedin Youtube
      Categories
      • Antibiotic reduction
      • Field experience
      • Footrot
      • Mastitis
      • Other Goats, Sheep and Lamb Diseases
      • Reproductive
      • Respiratory

      Pages

      • Blog
      • Videos
      • About us
      • Contact

      HIPRA ©2025 All rights reserved

      • Cookie policy
      • Terms of use
      • Privacy policy
      • Cookie policy
      • Terms of use
      • Privacy policy

      Mastitis control program

      Our 6-point mastitis control program is a set of structured measures and practices, validated to improve udder health and milk quality in dairy farms.



        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our
        Privacy Policy.

        For further information, please check our detailed information on Data Protection.
        close-link
        Powered by Convert Plus

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        ACCEPT
        DECLINE

        NEWSLETTER

        Don´t miss any updates

          I have read and agree to the Privacy Policy and Basic information on Data Protection.

          Informazioni di base sulla protezione dei dati personali:

          Titolare del trattamento: LABORATORIOS HIPRA, S.A.
          Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
          Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
          Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
          Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

          Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.

          Informations de base sur la protection des données personnelles :

          Contrôleur : LABORATORIOS HIPRA, S.A.
          Objectifs : Gérer la relation contractuelle et/ou commerciale avec HIPRA, y compris l'envoi de nouvelles, de promotions et d'invitations à des événements sponsorisés par HIPRA.
          Base légale : Exécution de la relation contractuelle et intérêt légitime d'HIPRA.
          Destinataires : Tiers auxquels HIPRA a confié le cloud computing, la sécurité, l'audit, le mailing, les aspects techniques et informatiques services de support, ainsi que les sociétés de son groupe.
          Droits : demander l'accès et la rectification ou l'effacement des données personnelles et d'autres droits comme expliqué dans les informations supplémentaires. Vous pouvez consulter les informations supplémentaires détaillées sur la protection des données dans notre Politique de confidentialité.

          Pour plus d'informations, veuillez consulter nos informations détaillées sur la protection des données. .

          Βασικές πληροφορίες προστασίας προσωπικών δεδομένων:

          Ελεγκτής: ΕΡΓΑΣΤΗΡΙΟ HIPRA, S.A.
          Σκοποί: Διαχείριση της συμβατικής ή/και επιχειρηματικής σχέσης με την HIPRA, συμπεριλαμβανομένης της αποστολής ειδήσεων, προωθήσεων και προσκλήσεων σε εκδηλώσεις που χρηματοδοτούνται από την HIPRA.
          Νόμιμη βάση: Εκτέλεση της συμβατικής σχέσης και έννομο συμφέρον της HIPRA.
          Παραλήπτες: Τρίτα μέρη στα οποία η HIPRA έχει εμπιστευθεί το cloud computing, την ασφάλεια, τον έλεγχο, την αλληλογραφία, την τεχνική και τον υπολογιστή υπηρεσίες υποστήριξης, καθώς και εταιρείες του ομίλου της.
          Δικαιώματα: Ζητήστε πρόσβαση και διόρθωση ή διαγραφή προσωπικών δεδομένων και άλλων δικαιωμάτων, όπως εξηγείται στις πρόσθετες πληροφορίες. Μπορείτε να δείτε αναλυτικές πρόσθετες πληροφορίες σχετικά με την προστασία δεδομένων στο Πολιτική Απορρήτου.

          Για περισσότερες πληροφορίες, ελέγξτε τις λεπτομερείς πληροφορίες σχετικά με την Προστασία Δεδομένων .

          Información básica sobre protección de datos:

          Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
          Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
          Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
          Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
          Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

          Para obtener más información, consulte nuestra información detallada sobre Protección de datos.

          Basic Personal Data Protection information:

          Controller: LABORATORIOS HIPRA, S.A.
          Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
          Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
          Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
          Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

          For further information, please check our detailed information on Data Protection.